Cargando…
Clinical pharmacokinetic properties of magnesium sulphate in women with pre‐eclampsia and eclampsia
BACKGROUND: The pharmacokinetic basis of magnesium sulphate (MgSO (4)) dosing regimens for eclampsia prophylaxis and treatment is not clearly established. OBJECTIVES: To review available data on clinical pharmacokinetic properties of MgSO (4) when used for women with pre‐eclampsia and/or eclampsia....
Autores principales: | Okusanya, BO, Oladapo, OT, Long, Q, Lumbiganon, P, Carroli, G, Qureshi, Z, Duley, L, Souza, JP, Gülmezoglu, AM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737322/ https://www.ncbi.nlm.nih.gov/pubmed/26599617 http://dx.doi.org/10.1111/1471-0528.13753 |
Ejemplares similares
-
Clinical practice patterns on the use of magnesium sulphate for treatment of pre‐eclampsia and eclampsia: a multi‐country survey
por: Long, Q, et al.
Publicado: (2016) -
Factors affecting use of magnesium sulphate for pre‐eclampsia or eclampsia: a qualitative evidence synthesis
por: Eddy, KE, et al.
Publicado: (2021) -
Treatment of Eclampsia with Magnesium Sulphate
por: Quddus, M. A.
Publicado: (1946) -
Maternal outcomes of magnesium sulphate and diazepam use in women with severe
pre-eclampsia and eclampsia in Ethiopia
por: Kassie, Gizat M., et al.
Publicado: (2014) -
Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia
por: Aaserud, Morten, et al.
Publicado: (2005)